Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Haemonetics cardioPAT Cardiovascular Perioperative Autotransfusion System

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Haemonetics cardioPAT Cardiovascular Perioperative Autotransfusion System see related information
Date Initiated by Firm July 27, 2011
Date Posted August 05, 2011
Recall Status1 Terminated 3 on June 09, 2014
Recall Number Z-2956-2011
Recall Event ID 59379
510(K)Number K053000  
Product Classification Apparatus, autotransfusion - Product Code CAC
Product Haemonetics cardioPAT -Cardiovascular Perioperative Autotransfusion System
Model 2050 US
Models Out-Side the US:
02050-UK, 02050-ES, 02050-IT, 02050-NL, 02050-GE, 02050-FR, 02050-JA

The Haemonetics¿ Cardiovascular Perioperative Autotransfusion System
for Use (cardioPAT) is indicated for use to salvage red blood cells from blood lost intraoperatively and postoperatively during cardiovascular surgical
procedures, where the expected rate of processing of salvaged blood and fluid
aspirated from the surgical site is less than or equal to two liters per hour.
Code Information All serial numbers
Recalling Firm/
Manufacturer		 Haemonetics Corporation
400 Wood Rd
Braintree MA 02184-2412
For Additional Information Contact SAME
781-848-7100
Manufacturer Reason
for Recall		 Updated Operations Manual for the deployment of the spill collection system and cleaning
FDA Determined
Cause 2		 Component design/selection
Action Haemonetics sent a "FIELD NOTIFICATION: UPDATE OF CardioPAT OPERATIONS MANUAL FOR DEPLOYMENT OF SPILL COLLECTION BAG AND CLEANING" letter dated July 27, 2011 to all affected customers. The letter describes the product, problem, and the actions to be taken by the customers. The letter requests that customers complete an enclosed Customer Confirmation sheet indicating that the affected devices are in their possession and to return the sheet via fax to Haemonetics at 781-987-9252. Additionally, instructions for deployment of the spill collection drainage system, revised Operations Manual and Quick Reference Guide Addendum are enclosed with the letter. Contact Haemonetics at 1-800-537-2802 for questions regarding this notice..
Quantity in Commerce 316 units
Distribution Worldwide Distribution--USA (nationwide) and the countries of Canada, France, Germany, Great Britain, Italy, Japan, Spain, and The Netherlands.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = CAC and Original Applicant = HAEMONETICS CORP.
-
-